nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ABCG2—primary biliary cirrhosis	0.622	1	CbGaD
Afatinib—ERBB2—gall bladder—primary biliary cirrhosis	0.00732	0.2	CbGeAlD
Afatinib—Interstitial lung disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00389	0.0253	CcSEcCtD
Afatinib—Interstitial lung disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00389	0.0253	CcSEcCtD
Afatinib—ERBB4—epithelium—primary biliary cirrhosis	0.00379	0.103	CbGeAlD
Afatinib—ERBB2—epithelium—primary biliary cirrhosis	0.00379	0.103	CbGeAlD
Afatinib—ERBB2—smooth muscle tissue—primary biliary cirrhosis	0.00365	0.0996	CbGeAlD
Afatinib—Bladder pain—Colchicine—primary biliary cirrhosis	0.00277	0.018	CcSEcCtD
Afatinib—IRAK1—smooth muscle tissue—primary biliary cirrhosis	0.00273	0.0745	CbGeAlD
Afatinib—Cystitis noninfective—Ursodeoxycholic acid—primary biliary cirrhosis	0.00269	0.0175	CcSEcCtD
Afatinib—Cystitis noninfective—Chenodeoxycholic acid—primary biliary cirrhosis	0.00269	0.0175	CcSEcCtD
Afatinib—Cystitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00266	0.0173	CcSEcCtD
Afatinib—Cystitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00266	0.0173	CcSEcCtD
Afatinib—Bladder pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00249	0.0162	CcSEcCtD
Afatinib—Bladder pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00249	0.0162	CcSEcCtD
Afatinib—PHKG2—liver—primary biliary cirrhosis	0.00239	0.0652	CbGeAlD
Afatinib—ERBB2—liver—primary biliary cirrhosis	0.00215	0.0586	CbGeAlD
Afatinib—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.0021	0.0136	CcSEcCtD
Afatinib—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.0021	0.0136	CcSEcCtD
Afatinib—Dehydration—Colchicine—primary biliary cirrhosis	0.00207	0.0134	CcSEcCtD
Afatinib—DYRK1A—liver—primary biliary cirrhosis	0.00207	0.0564	CbGeAlD
Afatinib—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.002	0.013	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00196	0.0127	CcSEcCtD
Afatinib—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00186	0.0121	CcSEcCtD
Afatinib—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00186	0.0121	CcSEcCtD
Afatinib—EGFR—liver—primary biliary cirrhosis	0.00182	0.0497	CbGeAlD
Afatinib—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0018	0.0117	CcSEcCtD
Afatinib—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0018	0.0117	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00176	0.0114	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00176	0.0114	CcSEcCtD
Afatinib—Stomatitis—Colchicine—primary biliary cirrhosis	0.00167	0.0109	CcSEcCtD
Afatinib—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00161	0.0104	CcSEcCtD
Afatinib—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00161	0.0104	CcSEcCtD
Afatinib—IRAK1—liver—primary biliary cirrhosis	0.00161	0.0438	CbGeAlD
Afatinib—LCK—liver—primary biliary cirrhosis	0.00157	0.0427	CbGeAlD
Afatinib—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00156	0.0102	CcSEcCtD
Afatinib—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00156	0.0102	CcSEcCtD
Afatinib—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00155	0.0101	CcSEcCtD
Afatinib—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00155	0.0101	CcSEcCtD
Afatinib—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.01	CcSEcCtD
Afatinib—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.01	CcSEcCtD
Afatinib—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.01	CcSEcCtD
Afatinib—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.01	CcSEcCtD
Afatinib—ABL1—smooth muscle tissue—primary biliary cirrhosis	0.00153	0.0417	CbGeAlD
Afatinib—Vandetanib—ABCG2—primary biliary cirrhosis	0.00152	0.357	CrCbGaD
Afatinib—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00983	CcSEcCtD
Afatinib—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00983	CcSEcCtD
Afatinib—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0015	0.00972	CcSEcCtD
Afatinib—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0015	0.00972	CcSEcCtD
Afatinib—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.0015	0.00972	CcSEcCtD
Afatinib—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.0015	0.00972	CcSEcCtD
Afatinib—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00946	CcSEcCtD
Afatinib—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00946	CcSEcCtD
Afatinib—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00145	0.00944	CcSEcCtD
Afatinib—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00145	0.00944	CcSEcCtD
Afatinib—Gefitinib—ABCG2—primary biliary cirrhosis	0.00145	0.339	CrCbGaD
Afatinib—Eye disorder—Colchicine—primary biliary cirrhosis	0.00144	0.00934	CcSEcCtD
Afatinib—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00139	0.00901	CcSEcCtD
Afatinib—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00887	CcSEcCtD
Afatinib—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00887	CcSEcCtD
Afatinib—Alopecia—Colchicine—primary biliary cirrhosis	0.00136	0.00883	CcSEcCtD
Afatinib—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00882	CcSEcCtD
Afatinib—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00882	CcSEcCtD
Afatinib—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.0088	CcSEcCtD
Afatinib—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.0088	CcSEcCtD
Afatinib—Malnutrition—Colchicine—primary biliary cirrhosis	0.00134	0.0087	CcSEcCtD
Afatinib—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00839	CcSEcCtD
Afatinib—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00839	CcSEcCtD
Afatinib—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00129	0.00836	CcSEcCtD
Afatinib—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00809	CcSEcCtD
Afatinib—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00809	CcSEcCtD
Afatinib—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00794	CcSEcCtD
Afatinib—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00122	0.00794	CcSEcCtD
Afatinib—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00782	CcSEcCtD
Afatinib—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00782	CcSEcCtD
Afatinib—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00756	CcSEcCtD
Afatinib—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00756	CcSEcCtD
Afatinib—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00752	CcSEcCtD
Afatinib—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00752	CcSEcCtD
Afatinib—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00107	0.00696	CcSEcCtD
Afatinib—Skin disorder—Colchicine—primary biliary cirrhosis	0.00106	0.0069	CcSEcCtD
Afatinib—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00105	0.00682	CcSEcCtD
Afatinib—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00105	0.00682	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00661	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00661	CcSEcCtD
Afatinib—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000976	0.00634	CcSEcCtD
Afatinib—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000976	0.00634	CcSEcCtD
Afatinib—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000964	0.00626	CcSEcCtD
Afatinib—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000964	0.00626	CcSEcCtD
Afatinib—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000955	0.0062	CcSEcCtD
Afatinib—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000955	0.0062	CcSEcCtD
Afatinib—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000951	0.00617	CcSEcCtD
Afatinib—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000944	0.00613	CcSEcCtD
Afatinib—Fatigue—Colchicine—primary biliary cirrhosis	0.000943	0.00612	CcSEcCtD
Afatinib—ABL1—liver—primary biliary cirrhosis	0.0009	0.0246	CbGeAlD
Afatinib—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000889	0.00577	CcSEcCtD
Afatinib—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000889	0.00577	CcSEcCtD
Afatinib—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000876	0.00569	CcSEcCtD
Afatinib—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000876	0.00569	CcSEcCtD
Afatinib—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000865	0.00562	CcSEcCtD
Afatinib—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000865	0.00562	CcSEcCtD
Afatinib—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000854	0.00555	CcSEcCtD
Afatinib—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000854	0.00555	CcSEcCtD
Afatinib—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000849	0.00551	CcSEcCtD
Afatinib—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000849	0.00551	CcSEcCtD
Afatinib—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000847	0.0055	CcSEcCtD
Afatinib—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000847	0.0055	CcSEcCtD
Afatinib—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00084	0.00546	CcSEcCtD
Afatinib—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00084	0.00546	CcSEcCtD
Afatinib—Asthenia—Colchicine—primary biliary cirrhosis	0.000785	0.00509	CcSEcCtD
Afatinib—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000777	0.00504	CcSEcCtD
Afatinib—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000777	0.00504	CcSEcCtD
Afatinib—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000748	0.00486	CcSEcCtD
Afatinib—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000705	0.00458	CcSEcCtD
Afatinib—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000705	0.00458	CcSEcCtD
Afatinib—Vomiting—Colchicine—primary biliary cirrhosis	0.000696	0.00451	CcSEcCtD
Afatinib—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000695	0.00451	CcSEcCtD
Afatinib—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000695	0.00451	CcSEcCtD
Afatinib—Rash—Colchicine—primary biliary cirrhosis	0.00069	0.00448	CcSEcCtD
Afatinib—Dermatitis—Colchicine—primary biliary cirrhosis	0.000689	0.00447	CcSEcCtD
Afatinib—Headache—Colchicine—primary biliary cirrhosis	0.000685	0.00445	CcSEcCtD
Afatinib—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000672	0.00437	CcSEcCtD
Afatinib—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000672	0.00437	CcSEcCtD
Afatinib—Vandetanib—ALB—primary biliary cirrhosis	0.000665	0.156	CrCbGaD
Afatinib—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00065	0.00422	CcSEcCtD
Afatinib—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00065	0.00422	CcSEcCtD
Afatinib—Nausea—Colchicine—primary biliary cirrhosis	0.00065	0.00422	CcSEcCtD
Afatinib—Gefitinib—ALB—primary biliary cirrhosis	0.000631	0.148	CrCbGaD
Afatinib—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000625	0.00406	CcSEcCtD
Afatinib—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000625	0.00406	CcSEcCtD
Afatinib—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00062	0.00402	CcSEcCtD
Afatinib—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00062	0.00402	CcSEcCtD
Afatinib—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000619	0.00402	CcSEcCtD
Afatinib—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000619	0.00402	CcSEcCtD
Afatinib—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000616	0.004	CcSEcCtD
Afatinib—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000616	0.004	CcSEcCtD
Afatinib—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000584	0.00379	CcSEcCtD
Afatinib—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000584	0.00379	CcSEcCtD
Afatinib—ABCG2—liver—primary biliary cirrhosis	0.000567	0.0155	CbGeAlD
Afatinib—ABCB1—epithelium—primary biliary cirrhosis	0.000494	0.0135	CbGeAlD
Afatinib—ABCB1—liver—primary biliary cirrhosis	0.00028	0.00763	CbGeAlD
Afatinib—PHKG2—Disease—TYK2—primary biliary cirrhosis	5.88e-05	0.000321	CbGpPWpGaD
Afatinib—BLK—Immune System—CD79A—primary biliary cirrhosis	5.84e-05	0.000319	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—CD80—primary biliary cirrhosis	5.84e-05	0.000319	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CXCR5—primary biliary cirrhosis	5.79e-05	0.000316	CbGpPWpGaD
Afatinib—EGFR—Immune System—MAP3K14—primary biliary cirrhosis	5.78e-05	0.000316	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	5.78e-05	0.000316	CbGpPWpGaD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	5.77e-05	0.000315	CbGpPWpGaD
Afatinib—LCK—NGF signalling via TRKA from the plasma membrane—TYK2—primary biliary cirrhosis	5.75e-05	0.000314	CbGpPWpGaD
Afatinib—BLK—Immune System—TAB1—primary biliary cirrhosis	5.73e-05	0.000313	CbGpPWpGaD
Afatinib—ERBB2—Disease—GOT1—primary biliary cirrhosis	5.62e-05	0.000307	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—ALB—primary biliary cirrhosis	5.58e-05	0.000305	CbGpPWpGaD
Afatinib—LCK—Immune System—MAP3K14—primary biliary cirrhosis	5.57e-05	0.000305	CbGpPWpGaD
Afatinib—ERBB4—Disease—GOT1—primary biliary cirrhosis	5.54e-05	0.000302	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PDHX—primary biliary cirrhosis	5.51e-05	0.000301	CbGpPWpGaD
Afatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—primary biliary cirrhosis	5.5e-05	0.000301	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—NFKB1—primary biliary cirrhosis	5.48e-05	0.000299	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—NFKB1—primary biliary cirrhosis	5.44e-05	0.000297	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—CD80—primary biliary cirrhosis	5.44e-05	0.000297	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—TYK2—primary biliary cirrhosis	5.42e-05	0.000296	CbGpPWpGaD
Afatinib—IRAK1—Signaling by NGF—NFKB1—primary biliary cirrhosis	5.35e-05	0.000292	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—TYK2—primary biliary cirrhosis	5.34e-05	0.000292	CbGpPWpGaD
Afatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—primary biliary cirrhosis	5.3e-05	0.00029	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CXCL9—primary biliary cirrhosis	5.26e-05	0.000287	CbGpPWpGaD
Afatinib—EGFR—Fc epsilon receptor (FCERI) signaling—NFKB1—primary biliary cirrhosis	5.25e-05	0.000287	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—CD80—primary biliary cirrhosis	5.24e-05	0.000286	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—DLAT—primary biliary cirrhosis	5.18e-05	0.000283	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ABCB4—primary biliary cirrhosis	5.18e-05	0.000283	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CTLA4—primary biliary cirrhosis	5.15e-05	0.000281	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—MMP2—primary biliary cirrhosis	5.1e-05	0.000278	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—PPARGC1A—primary biliary cirrhosis	5.09e-05	0.000278	CbGpPWpGaD
Afatinib—LCK—Fc epsilon receptor (FCERI) signaling—NFKB1—primary biliary cirrhosis	5.06e-05	0.000277	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—ALB—primary biliary cirrhosis	5.05e-05	0.000276	CbGpPWpGaD
Afatinib—ABL1—Immune System—NUP210—primary biliary cirrhosis	5.05e-05	0.000276	CbGpPWpGaD
Afatinib—EGFR—Immune System—ELMO1—primary biliary cirrhosis	5.03e-05	0.000275	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CD40LG—primary biliary cirrhosis	5.02e-05	0.000275	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—TAB1—primary biliary cirrhosis	5.02e-05	0.000274	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CTLA4—primary biliary cirrhosis	4.96e-05	0.000271	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CD40LG—primary biliary cirrhosis	4.95e-05	0.00027	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	4.94e-05	0.00027	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD79A—primary biliary cirrhosis	4.91e-05	0.000268	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—ELMO1—primary biliary cirrhosis	4.87e-05	0.000266	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—TYK2—primary biliary cirrhosis	4.86e-05	0.000266	CbGpPWpGaD
Afatinib—EGFR—B Cell Activation—NFKB1—primary biliary cirrhosis	4.86e-05	0.000266	CbGpPWpGaD
Afatinib—LCK—Immune System—ELMO1—primary biliary cirrhosis	4.85e-05	0.000265	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—TAB1—primary biliary cirrhosis	4.84e-05	0.000264	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—MMP9—primary biliary cirrhosis	4.83e-05	0.000264	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—NFKB1—primary biliary cirrhosis	4.78e-05	0.000261	CbGpPWpGaD
Afatinib—BLK—Immune System—CD40LG—primary biliary cirrhosis	4.76e-05	0.00026	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD79A—primary biliary cirrhosis	4.73e-05	0.000259	CbGpPWpGaD
Afatinib—LCK—B Cell Activation—NFKB1—primary biliary cirrhosis	4.68e-05	0.000256	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CTLA4—primary biliary cirrhosis	4.67e-05	0.000255	CbGpPWpGaD
Afatinib—EGFR—Disease—ELMO1—primary biliary cirrhosis	4.65e-05	0.000254	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—CD80—primary biliary cirrhosis	4.64e-05	0.000254	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—LBR—primary biliary cirrhosis	4.62e-05	0.000253	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—TYK2—primary biliary cirrhosis	4.59e-05	0.000251	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—TYK2—primary biliary cirrhosis	4.5e-05	0.000246	CbGpPWpGaD
Afatinib—LCK—Disease—ELMO1—primary biliary cirrhosis	4.48e-05	0.000245	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD79A—primary biliary cirrhosis	4.46e-05	0.000244	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—TYK2—primary biliary cirrhosis	4.42e-05	0.000242	CbGpPWpGaD
Afatinib—IRAK1—Immune System—TAB1—primary biliary cirrhosis	4.37e-05	0.000239	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—MMP2—primary biliary cirrhosis	4.35e-05	0.000238	CbGpPWpGaD
Afatinib—EGFR—Immune System—NUP210—primary biliary cirrhosis	4.31e-05	0.000236	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—NFKB1—primary biliary cirrhosis	4.22e-05	0.000231	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—NFKB1—primary biliary cirrhosis	4.16e-05	0.000227	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—NOS2—primary biliary cirrhosis	4.16e-05	0.000227	CbGpPWpGaD
Afatinib—LCK—Immune System—NUP210—primary biliary cirrhosis	4.16e-05	0.000227	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—TYK2—primary biliary cirrhosis	4.16e-05	0.000227	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	4.1e-05	0.000224	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—NFKB1—primary biliary cirrhosis	4.05e-05	0.000221	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CDH5—primary biliary cirrhosis	4.02e-05	0.00022	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD40LG—primary biliary cirrhosis	4e-05	0.000219	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—NFKB1—primary biliary cirrhosis	3.99e-05	0.000218	CbGpPWpGaD
Afatinib—EGFR—Disease—NUP210—primary biliary cirrhosis	3.98e-05	0.000218	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	3.93e-05	0.000215	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—TYK2—primary biliary cirrhosis	3.92e-05	0.000214	CbGpPWpGaD
Afatinib—ERBB2—Disease—HIF1A—primary biliary cirrhosis	3.91e-05	0.000214	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CDH5—primary biliary cirrhosis	3.88e-05	0.000212	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCR5—primary biliary cirrhosis	3.87e-05	0.000212	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD40LG—primary biliary cirrhosis	3.86e-05	0.000211	CbGpPWpGaD
Afatinib—ERBB4—Disease—HIF1A—primary biliary cirrhosis	3.85e-05	0.00021	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—NFKB1—primary biliary cirrhosis	3.84e-05	0.00021	CbGpPWpGaD
Afatinib—LCK—Disease—NUP210—primary biliary cirrhosis	3.84e-05	0.00021	CbGpPWpGaD
Afatinib—ABL1—Axon guidance—MMP9—primary biliary cirrhosis	3.83e-05	0.000209	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.79e-05	0.000207	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CD80—primary biliary cirrhosis	3.74e-05	0.000204	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.73e-05	0.000204	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCR5—primary biliary cirrhosis	3.73e-05	0.000204	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CD80—primary biliary cirrhosis	3.68e-05	0.000201	CbGpPWpGaD
Afatinib—ABL1—Immune System—CTLA4—primary biliary cirrhosis	3.66e-05	0.0002	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—MMP2—primary biliary cirrhosis	3.64e-05	0.000199	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD40LG—primary biliary cirrhosis	3.63e-05	0.000199	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—CD80—primary biliary cirrhosis	3.63e-05	0.000198	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	3.59e-05	0.000196	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—NFKB1—primary biliary cirrhosis	3.58e-05	0.000196	CbGpPWpGaD
Afatinib—ERBB2—Disease—NOS2—primary biliary cirrhosis	3.56e-05	0.000194	CbGpPWpGaD
Afatinib—BLK—Immune System—CD80—primary biliary cirrhosis	3.54e-05	0.000194	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCL9—primary biliary cirrhosis	3.52e-05	0.000192	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—NFKB1—primary biliary cirrhosis	3.51e-05	0.000192	CbGpPWpGaD
Afatinib—ERBB4—Disease—NOS2—primary biliary cirrhosis	3.5e-05	0.000191	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—ALB—primary biliary cirrhosis	3.49e-05	0.000191	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD79A—primary biliary cirrhosis	3.49e-05	0.000191	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TYK2—primary biliary cirrhosis	3.47e-05	0.00019	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—MMP3—primary biliary cirrhosis	3.46e-05	0.000189	CbGpPWpGaD
Afatinib—ERBB2—Disease—CD80—primary biliary cirrhosis	3.45e-05	0.000189	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—NFKB1—primary biliary cirrhosis	3.45e-05	0.000188	CbGpPWpGaD
Afatinib—ABL1—Immune System—TAB1—primary biliary cirrhosis	3.42e-05	0.000187	CbGpPWpGaD
Afatinib—LCK—Hemostasis—NOS2—primary biliary cirrhosis	3.42e-05	0.000187	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—MMP3—primary biliary cirrhosis	3.4e-05	0.000186	CbGpPWpGaD
Afatinib—ERBB4—Disease—CD80—primary biliary cirrhosis	3.4e-05	0.000186	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCL9—primary biliary cirrhosis	3.39e-05	0.000185	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	3.34e-05	0.000183	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	3.34e-05	0.000183	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—MMP9—primary biliary cirrhosis	3.27e-05	0.000179	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CCL5—primary biliary cirrhosis	3.26e-05	0.000178	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ELMO1—primary biliary cirrhosis	3.25e-05	0.000178	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CCL5—primary biliary cirrhosis	3.21e-05	0.000176	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.16e-05	0.000173	CbGpPWpGaD
Afatinib—ERBB2—Immune System—TYK2—primary biliary cirrhosis	3.16e-05	0.000172	CbGpPWpGaD
Afatinib—EGFR—Disease—GOT2—primary biliary cirrhosis	3.15e-05	0.000172	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ELMO1—primary biliary cirrhosis	3.14e-05	0.000171	CbGpPWpGaD
Afatinib—EGFR—Immune System—CTLA4—primary biliary cirrhosis	3.12e-05	0.000171	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—NUP210—primary biliary cirrhosis	3.11e-05	0.00017	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.11e-05	0.00017	CbGpPWpGaD
Afatinib—ERBB4—Immune System—TYK2—primary biliary cirrhosis	3.11e-05	0.00017	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—MMP2—primary biliary cirrhosis	3.11e-05	0.00017	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—CD80—primary biliary cirrhosis	3.1e-05	0.00017	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CXCL10—primary biliary cirrhosis	3.1e-05	0.000169	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—TYK2—primary biliary cirrhosis	3.06e-05	0.000167	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—NFKB1—primary biliary cirrhosis	3.05e-05	0.000167	CbGpPWpGaD
Afatinib—LCK—Disease—GOT2—primary biliary cirrhosis	3.03e-05	0.000166	CbGpPWpGaD
Afatinib—LCK—Immune System—CTLA4—primary biliary cirrhosis	3.01e-05	0.000164	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—CD80—primary biliary cirrhosis	2.99e-05	0.000163	CbGpPWpGaD
Afatinib—BLK—Immune System—TYK2—primary biliary cirrhosis	2.99e-05	0.000163	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD79A—primary biliary cirrhosis	2.98e-05	0.000163	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD80—primary biliary cirrhosis	2.98e-05	0.000163	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	2.98e-05	0.000163	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TYK2—primary biliary cirrhosis	2.97e-05	0.000162	CbGpPWpGaD
Afatinib—EGFR—Immune System—TAB1—primary biliary cirrhosis	2.92e-05	0.00016	CbGpPWpGaD
Afatinib—ERBB2—Disease—TYK2—primary biliary cirrhosis	2.91e-05	0.000159	CbGpPWpGaD
Afatinib—LCK—Hemostasis—ALB—primary biliary cirrhosis	2.88e-05	0.000157	CbGpPWpGaD
Afatinib—LCK—Immune System—CD79A—primary biliary cirrhosis	2.87e-05	0.000157	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD80—primary biliary cirrhosis	2.87e-05	0.000157	CbGpPWpGaD
Afatinib—ERBB4—Disease—TYK2—primary biliary cirrhosis	2.87e-05	0.000157	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD40LG—primary biliary cirrhosis	2.84e-05	0.000155	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—MMP3—primary biliary cirrhosis	2.83e-05	0.000155	CbGpPWpGaD
Afatinib—LCK—Immune System—TAB1—primary biliary cirrhosis	2.82e-05	0.000154	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	2.8e-05	0.000153	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	2.8e-05	0.000153	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.74e-05	0.00015	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.74e-05	0.00015	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—MMP9—primary biliary cirrhosis	2.73e-05	0.000149	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—AGT—primary biliary cirrhosis	2.73e-05	0.000149	CbGpPWpGaD
Afatinib—EGFR—Disease—GOT1—primary biliary cirrhosis	2.72e-05	0.000148	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—NFKB1—primary biliary cirrhosis	2.7e-05	0.000148	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD80—primary biliary cirrhosis	2.7e-05	0.000148	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.7e-05	0.000147	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—AGT—primary biliary cirrhosis	2.69e-05	0.000147	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CCL5—primary biliary cirrhosis	2.67e-05	0.000146	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—TYK2—primary biliary cirrhosis	2.62e-05	0.000143	CbGpPWpGaD
Afatinib—LCK—Disease—GOT1—primary biliary cirrhosis	2.62e-05	0.000143	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—TYK2—primary biliary cirrhosis	2.52e-05	0.000138	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—MMP3—primary biliary cirrhosis	2.5e-05	0.000137	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	2.49e-05	0.000136	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CTGF—primary biliary cirrhosis	2.48e-05	0.000136	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GOT2—primary biliary cirrhosis	2.46e-05	0.000134	CbGpPWpGaD
Afatinib—ERBB2—Immune System—NFKB1—primary biliary cirrhosis	2.46e-05	0.000134	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD40LG—primary biliary cirrhosis	2.43e-05	0.000133	CbGpPWpGaD
Afatinib—ERBB4—Immune System—NFKB1—primary biliary cirrhosis	2.42e-05	0.000132	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CD80—primary biliary cirrhosis	2.42e-05	0.000132	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.41e-05	0.000132	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—NFKB1—primary biliary cirrhosis	2.39e-05	0.00013	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CD80—primary biliary cirrhosis	2.38e-05	0.00013	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CCL5—primary biliary cirrhosis	2.36e-05	0.000129	CbGpPWpGaD
Afatinib—LCK—Immune System—CD40LG—primary biliary cirrhosis	2.34e-05	0.000128	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—MMP9—primary biliary cirrhosis	2.34e-05	0.000128	CbGpPWpGaD
Afatinib—BLK—Immune System—NFKB1—primary biliary cirrhosis	2.33e-05	0.000127	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—NFKB1—primary biliary cirrhosis	2.31e-05	0.000126	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.28e-05	0.000125	CbGpPWpGaD
Afatinib—IRAK1—Immune System—TYK2—primary biliary cirrhosis	2.28e-05	0.000125	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—AGT—primary biliary cirrhosis	2.23e-05	0.000122	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GOT1—primary biliary cirrhosis	2.12e-05	0.000116	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GGT1—primary biliary cirrhosis	2.12e-05	0.000116	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD80—primary biliary cirrhosis	2.11e-05	0.000116	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—NFKB1—primary biliary cirrhosis	2.04e-05	0.000112	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TYK2—primary biliary cirrhosis	2.04e-05	0.000111	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TYK2—primary biliary cirrhosis	2.01e-05	0.00011	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.98e-05	0.000108	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—AGT—primary biliary cirrhosis	1.97e-05	0.000108	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—NFKB1—primary biliary cirrhosis	1.97e-05	0.000107	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.96e-05	0.000107	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.89e-05	0.000103	CbGpPWpGaD
Afatinib—EGFR—Disease—HIF1A—primary biliary cirrhosis	1.89e-05	0.000103	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.89e-05	0.000103	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.83e-05	0.0001	CbGpPWpGaD
Afatinib—LCK—Disease—HIF1A—primary biliary cirrhosis	1.82e-05	9.95e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD80—primary biliary cirrhosis	1.81e-05	9.87e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—TYK2—primary biliary cirrhosis	1.79e-05	9.75e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—NFKB1—primary biliary cirrhosis	1.78e-05	9.71e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.76e-05	9.64e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CD80—primary biliary cirrhosis	1.75e-05	9.55e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—CD80—primary biliary cirrhosis	1.74e-05	9.52e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—NOS2—primary biliary cirrhosis	1.72e-05	9.4e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	1.68e-05	9.2e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MMP3—primary biliary cirrhosis	1.67e-05	9.13e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—TYK2—primary biliary cirrhosis	1.67e-05	9.12e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—CD80—primary biliary cirrhosis	1.67e-05	9.12e-05	CbGpPWpGaD
Afatinib—LCK—Disease—NOS2—primary biliary cirrhosis	1.66e-05	9.05e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MMP3—primary biliary cirrhosis	1.61e-05	8.8e-05	CbGpPWpGaD
Afatinib—LCK—Disease—CD80—primary biliary cirrhosis	1.61e-05	8.79e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—MMP9—primary biliary cirrhosis	1.61e-05	8.78e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.59e-05	8.69e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—MMP9—primary biliary cirrhosis	1.58e-05	8.65e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCL5—primary biliary cirrhosis	1.58e-05	8.61e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.57e-05	8.56e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	1.56e-05	8.55e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.53e-05	8.35e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—TYK2—primary biliary cirrhosis	1.53e-05	8.34e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCL5—primary biliary cirrhosis	1.52e-05	8.3e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TYK2—primary biliary cirrhosis	1.47e-05	8.06e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—AGT—primary biliary cirrhosis	1.47e-05	8.05e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.47e-05	8.05e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—TYK2—primary biliary cirrhosis	1.47e-05	8.03e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—TYK2—primary biliary cirrhosis	1.41e-05	7.7e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—NFKB1—primary biliary cirrhosis	1.39e-05	7.6e-05	CbGpPWpGaD
Afatinib—LCK—Disease—TYK2—primary biliary cirrhosis	1.36e-05	7.42e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	1.34e-05	7.34e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	1.33e-05	7.27e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.32e-05	7.23e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AGT—primary biliary cirrhosis	1.32e-05	7.21e-05	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.3e-05	7.13e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.28e-05	6.97e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AGT—primary biliary cirrhosis	1.27e-05	6.94e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—NFKB1—primary biliary cirrhosis	1.19e-05	6.49e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CD80—primary biliary cirrhosis	1.17e-05	6.38e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—MMP9—primary biliary cirrhosis	1.16e-05	6.35e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.15e-05	6.28e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	1.15e-05	6.28e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	1.15e-05	6.28e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—NFKB1—primary biliary cirrhosis	1.15e-05	6.26e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—ALB—primary biliary cirrhosis	1.13e-05	6.17e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CD80—primary biliary cirrhosis	1.13e-05	6.15e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.02e-05	5.58e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TYK2—primary biliary cirrhosis	9.86e-06	5.39e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TYK2—primary biliary cirrhosis	9.5e-06	5.19e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—AGT—primary biliary cirrhosis	7.96e-06	4.35e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MMP9—primary biliary cirrhosis	7.77e-06	4.24e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NFKB1—primary biliary cirrhosis	7.68e-06	4.2e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MMP9—primary biliary cirrhosis	7.48e-06	4.09e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NFKB1—primary biliary cirrhosis	7.41e-06	4.05e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ALB—primary biliary cirrhosis	6.11e-06	3.34e-05	CbGpPWpGaD
